83
Views
32
CrossRef citations to date
0
Altmetric
Original Research

miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples

, , , , , , , & show all
Pages 4225-4238 | Published online: 28 Aug 2017

References

  • AznaurovaYBZhumataevMBRobertsTKAliperAMZhavoronkovAAMolecular aspects of development and regulation of endometriosisReprod Biol Endocrinol2014125024927773
  • LiuFSMolecular carcinogenesis of endometrial cancerTaiwan J Obstet Gynecol2007461263217389185
  • GuoSWEndometriosis and ovarian cancer: potential benefits and harms of screening and risk-reducing surgeryFertil Steril2015104481383026335131
  • LaudanskiPCharkiewiczRTolwinskaASzamatowiczJCharkiewiczANiklinskiJProfiling of selected microRNAs in proliferative eutopic endometrium of women with ovarian endometriosisBiomed Res Int2015201576069826366419
  • MandaiMYamaguchiKMatsumuraNBabaTKonishiIOvarian cancer in endometriosis: molecular biology, pathology, and clinical managementInt J Clin Oncol200914538339119856044
  • PavoneMELyttleBMEndometriosis and ovarian cancer: links, risks, and challenges facedInt J Womens Health2015766367226170722
  • BuisCCvan LeeuwenFEMooijTMBurgerCWOMEGA Project GroupIncreased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosisHum Reprod201328123358336924014607
  • SiegelRLMillerKDJemalACancer statistics, 2017CA Cancer J Clin201767173028055103
  • ManchandaRHalaskaMJPiekJMThe need for more workshops in laparoscopic surgery and surgical anatomy for European gynaecological oncology trainees: a survey by the European Network of Young Gynaecological OncologistsInt J Gynecol Cancer20132361127113223792606
  • VladCKubelacPAlexandruIAchimas-CadariuPThe role of primary debulking in advanced ovarian cancer patientsJ BUON2016215132027837639
  • SiegelRMaJZouZJemalACancer statistics, 2014CA Cancer J Clin201464192924399786
  • BuysSSPartridgeEBlackAEffect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled TrialJAMA2011305222295230321642681
  • IrimieAAchimas-CadariuPBurzCPuscasEMultiple primary malignancies – epidemiological analysis at a single tertiary institutionJ Gastrointestin Liver Dis2010191697320361078
  • KinoseYSawadaKNakamuraKKimuraTThe role of microRNAs in ovarian cancerBiomed Res Int2014201424939325295252
  • PavoneMELyttleBMEndometriosis and ovarian cancer: links, risks, and challenges facedInt J Womens Health2015766367226170722
  • Kondi-PafitiAPapakonstantinouEIavazzoCGrigoriadisCSalakosNGregoriouOClinicopathological characteristics of ovarian carcinomas associated with endometriosisArch Gynecol Obstet2012285247948321717140
  • SuryawanshiSVladAMLinH-MPlasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancerClin Cancer Res20131951213122423362326
  • Mahdian-ShakibADorostkarRTatMHashemzadehMSSaidiNDifferential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancerBiomed Pharmacother20168459260027694003
  • BraicuCCalinGABerindan-NeagoeIMicroRNAs and cancer therapy – from bystanders to major playersCurrent Med Chem2013202935613573
  • MuresanMZaharieFBojanAMicroRNAs in liver malignancies. Basic science applied in surgeryJ BUON201520236137526011324
  • BraicuCCojocneanu-PetricRChiraSClinical and pathological implications of miRNA in bladder cancerInt J Nanomedicine20151079180025653521
  • JanssonMDLundAHMicroRNA and cancerMol Oncol20126659061023102669
  • ChenXLuPWangDDThe role of miRNAs in drug resistance and prognosis of breast cancer formalin-fixed paraffin-embedded tissuesGene2016595222122627746365
  • IrimieAIBraicuCCojocneanu-PetricRBerindan-NeagoeICampianRSNovel technologies for oral squamous carcinoma biomarkers in diagnostics and prognosticsActa Odontol Scand201573316116825598447
  • Berindan-NeagoeICalinGAMolecular pathways: microRNAs, cancer cells, and microenvironmentClin Cancer Res201420246247625325512634
  • Berindan-NeagoeIMonroig PdelCPasculliBCalinGAMicroRNAome genome: a treasure for cancer diagnosis and therapyCA Cancer J Clin201464531133625104502
  • BraicuCCatanaCCalinGABerindan-NeagoeINCRNA combined therapy as future treatment option for cancerCurr Pharm Des201420426565657425341933
  • BraicuCTomuleasaCMonroigPCucuianuABerindan-NeagoeICalinGAExosomes as divine messengers: are they the Hermes of modern molecular oncology?Cell Death Differ2015221344525236394
  • Berindan-NeagoeIChioreanRBraicuCQuantitative mRNA expression of genes involved in angiogenesis, coagulation and inflammation in multiforme glioblastoma tumoral tissue versus peritumoral brain tissue: lack of correlation with clinical dataEur Cytokine Netw2012232455522591734
  • LiHHuangWLuoRThe microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1Diagn Pathol20151011726194496
  • YaoSZhaoTJinHExpression of MicroRNA-325-3p and its potential functions by targeting HMGB1 in non-small cell lung cancerBiomed Pharmacother201570727925776482
  • BannoKYanokuraMIidaMApplication of microRNA in diagnosis and treatment of ovarian cancerBiomed Res Int2014201423281724822185
  • WangYDongQGuYGroomeLJUp-regulation of miR-203 expression induces endothelial inflammatory response: potential role in preeclampsiaAm J Reprod Immunol201676648249027753461
  • LeeHChoiHJKangCSLeeHJLeeWSParkCSExpression of miRNAs and PTEN in endometrial specimens ranging from histologically normal to hyperplasia and endometrial adenocarcinomaMod Pathol201225111508151522766795
  • CaoQLuKDaiSHuYFanWClinicopathological and prognostic implications of the miR-200 family in patients with epithelial ovarian cancerInt J Clin Exp Pathol2014752392240124966949
  • HuXMacdonaldDMHuettnerPCA miR-200 microRNA cluster as prognostic marker in advanced ovarian cancerGynecol Oncol2009114345746419501389
  • ChenYZhangLHaoQCandidate microRNA biomarkers in human epithelial ovarian cancer: systematic review profiling studies and experimental validationCancer Cell Int20131318623978303
  • ZuberiMMirRDasJExpression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological featuresClin Transl Oncol2015171077978726063644
  • van JaarsveldMTHellemanJBoersmaAWmiR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cellsOncogene201332364284429323045278
  • YangRQTengHXuXHMicroarray analysis of microRNA deregulation and angiogenesis-related proteins in endometriosisGenet Mol Res2016152
  • RekkerKSaareMRoostAMCirculating miR-200-family micro-RNAs have altered plasma levels in patients with endometriosis and vary with blood collection timeFertil Steril20151044938946.e93226206343
  • LiB-AA novel tumor suppressor miRNA miR-520e contributes to suppression of hepatomaActa Pharmacol Sin20123313422212428
  • YiMLiMLongXmiR-520e regulates cell proliferation, apoptosis and migration in breast cancerOncol Lett20161253543354827900034
  • ZhangSShanCKongGDuYYeLZhangXMicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-[kappa] B-inducing kinase (NIK)Oncogene201231313607362022105365
  • ShenFCaiWSFengZMiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expressionTumour Biol20153631913192125407488
  • JiangYHanYSunCRab23 is overexpressed in human bladder cancer and promotes cancer cell proliferation and invasionTumour Biol20163768131813826715272
  • von FroweinJPagelPKapplerRvon SchweinitzDRoscherASchmidIMicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastomaHepatology201153383384221319197
  • Marzec-KotarskaBCybulskiMKotarskiJCMolecular bases of aberrant miR-182 expression in ovarian cancerGenes Chromosomes Cancer2016551187788927295517
  • LiuZLiuJSeguraMFMiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinomaJ Pathol2012228220421522322863
  • MengXJoosseSAMullerVDiagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patientsBr J Cancer201511391358136626393886
  • RoushSSlackFJThe let-7 family of microRNAsTrends Cell Biol2008181050551618774294
  • ZamanMSMaherDMKhanSJaggiMChauhanSCCurrent status and implications of microRNAs in ovarian cancer diagnosis and therapyJ Ovarian Res2012514423237306
  • OhJJGrosshansDRWongSGSlamonDJIdentification of differentially expressed genes associated with HER-2/neu overexpression in human breast cancer cellsNucleic Acids Res199927204008401710497265
  • IorioMVVisoneRDi LevaGMicroRNA signatures in human ovarian cancerCancer Res200767188699870717875710
  • SlackFJWeidhaasJBMicroRNA in cancer prognosisN Engl J Med2008359252720272219092157
  • YangNKaurSVoliniaSMicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancerCancer Res20086824103071031419074899
  • AoyagiYNasuKKaiKDecidualization differentially regulates microRNA expression in eutopic and ectopic endometrial stromal cellsReprod Sci201724344545527412773
  • ZhouJGongGTanHUrinary microRNA-30a-5p is a potential biomarker for ovarian serous adenocarcinomaOncol Rep20153362915292325962395
  • WangTLiFTangSMiR-30a upregulates BCL2A1, IER3 and cyclin D2 expression by targeting FOXL2Oncol Lett20159296797125621074
  • LiuJWuXLiuHExpression of microRNA-30a-5p in drug-resistant and drug-sensitive ovarian cancer cell linesOncol Lett20161232065207027602140
  • ZhuXLiYXieCmiR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6Int J Cancer201413561286129624510775
  • ChenXDongCLawPTMicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancerGynecol Oncol2015139351351926472353
  • AdammekMGreveBKassensNMicroRNA miR-145 inhibits proliferation, invasiveness, and stem cell phenotype of an in vitro endometriosis model by targeting multiple cytoskeletal elements and pluripotency factorsFertil Steril201399513461355.e134523312222
  • ZhouJLiuHChenYWenJLiLWuXExpression and significance of VEGF, miR-205 and target protein Ezrin and Lamin A/C in ovarian cancerZhong Nan Da Xue Xue Bao Yi Xue Ban2014392142150 Chinese24608381
  • LiJLiLLiZThe role of miR-205 in the VEGF-mediated promotion of human ovarian cancer cell invasionGynecol Oncol2015137112513325597268
  • NiuKShenWZhangYZhaoYLuYMiR-205 promotes motility of ovarian cancer cells via targeting ZEB1Gene2015574233033626275944
  • LiJHuKGongGUpregulation of MiR-205 transcriptionally suppresses SMAD4 and PTEN and contributes to human ovarian cancer progressionSci Rep201774133028145479
  • XuLXiangJShenJOncogenic MicroRNA-27a is a target for genistein in ovarian cancer cellsAnticancer Agents Med Chem20131371126113223438830
  • LiZHuSWangJMiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cellsGynecol Oncol2010119112513020624637
  • OnisimAAchimas-CadariuAVladCKubelacPAchimas-CadariuPCurrent insights into the association of Nestin with tumor angiogenesisJ BUON201520369970626214620
  • GhermanCBraicuOLZanoagaOCaffeic acid phenethyl ester activates pro-apoptotic and epithelial-mesenchymal transition-related genes in ovarian cancer cells A2780 and A2780cisMol Cell Biochem20164131–218919826838168